Request Sample Inquiry
Prostate Specific Antigen (psa) Testing Market

Prostate Specific Antigen (PSA) Testing Market

Prostate Specific Antigen (PSA) Testing Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

159

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1321

Segments Covered
  • By Test Type By Test Type Preliminary Tests, Confirmatory Tests
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 3.33 Billion
Revenue 2030Revenue 2030: USD 7.74 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 11.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. Global Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. Global Prostate Specific Antigen (PSA) Testing Market - by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. Global Prostate Specific Antigen (PSA) Testing Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    5. Market comparative analysis
  4. North America Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. North America Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. North America Prostate Specific Antigen (PSA) Testing Market, by Country
      1. U.S.
        1. U.S. Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      2. Canada
        1. Canada Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      3. Mexico
        1. Mexico Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
  5. Europe Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. Europe Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. Europe Prostate Specific Antigen (PSA) Testing Market, by Country
      1. Germany
        1. Germany Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      2. UK
        1. UK Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      3. France
        1. France Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      4. Spain
        1. Spain Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      5. Italy
        1. Italy Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      6. BENELUX
        1. BENELUX Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      7. Rest of Europe
        1. Rest Of Europe Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
  6. Asia Pacific Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. Asia Pacific Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Country
      1. China
        1. China Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      2. Japan
        1. Japan Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      3. India
        1. India Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      4. South Korea
        1. South Korea Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      5. South East Asia
        1. South East Asia Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
  7. Latin America Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. Latin America Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. Latin America Prostate Specific Antigen (PSA) Testing Market, by Country
      1. Brazil
        1. Brazil Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      2. Argentina
        1. Argentina Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      3. Rest of Latin America
        1. Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
  8. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
      1. By Preliminary Tests
      2. By Confirmatory Tests
    4. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Country
      1. GCC Countries
        1. GCC Countries Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      2. South Africa
        1. South Africa Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, By Test Type
          1. By Preliminary Tests
          2. By Confirmatory Tests
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. MDx Health (US)
    2. Myriad Genetics Inc (US).
    3. Abbott Laboratories (US)
    4. F. Hoffman-La Roche AG (Switzerland)
    5. Siemens Healthineers AG (Germany)
    6. OPKO Health Inc. (US)
    7. and Genomic Health (US).
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 24-Feb-2022
Prostate Specific Antigen (PSA) Testing Market Projected to Reach USD 5.83 Billion by 2028
FAQ
Frequently Asked Question

  • The global Prostate Specific Antigen (PSA) Testing valued at USD 3.33 Billion in 2022 and is expected to reach USD 7.74 Billion in 2030 growing at a CAGR of 11.10%.

  • The prominent players in the market are MDx Health (US), Myriad Genetics Inc (US)., Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), OPKO Health Inc. (US), and Genomic Health (US)..

  • The market is project to grow at a CAGR of 11.10% between 2023 and 2030.

  • The driving factors of the Prostate Specific Antigen (PSA) Testing include

    • Increased Level of Awareness

  • North America was the leading regional segment of the Prostate Specific Antigen (PSA) Testing in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy